Meningitis Vaccine Immunity Wanes: Urgent Booster Alert!

Dr. Ranj, a BBC doctor, has alerted the public to the possibility of contracting meningitis even after vaccination, emphasizing that immunity can diminish over time. This is particularly relevant for young individuals whose childhood vaccinations may no longer offer full protection. The MenB vaccine, a more recent addition to the UK schedule, provides immunity lasting between 5 to 9 years, meaning those in their late teens and early adulthood may lose protection.

Government guidance highlights that infants under one year, as well as teenagers and young adults, are at the highest risk for meningitis. Additionally, adults over 65 face increased risk from specific types like pneumococcal meningitis. Vaccination remains a primary method for protection, with all UK-approved vaccines undergoing rigorous safety and effectiveness testing by the MHRA.

The article notes that reports of meningitis often surface at the start of the academic year when students move to universities. This is because bacteria like meningococcus, which can cause bacterial meningitis, are more common carriers among teenagers and young adults. Close living quarters and shared items in universities facilitate the spread of these bacteria, increasing the risk for first-year students.

As of August 31, 2026, nearly a quarter of a million young people had received the MenB vaccine as part of an NHS initiative. However, two doses are required for full protection, and the NHS is urging eligible individuals, including those born between September 1, 2007, and August 31, 2008, and university entrants born after July 21, 2001, to book their second jab. First-year university students face approximately seven times the risk compared to their peers not attending university.